COVID-19 Records

Chairman Paul Letter to DNI Gabbard — page 43

of 56 pages · text recovered by OCR

← p.42 p.44 → · this page in the original PDF · package

Antiviral effect in primary human MERS-CoV Titer in HAE MERS-CoV RNA in HAE SARS-CoV Titer in HAE i (oom) 10% i ~ ® ae" vu GORFN I _ eo? é € 19% ~ ES . 6le £10 2 oda. vi £10 %6 2 o g ° < ry 3 @ & G5 U 2,54 ) U = 10) ae ® j ~ 10 ae} g 6-1 F 104 . F 1044 pe e ey @ a 8-2 g 24 B25 710) . #1077 wo" y pe uf a nn a s ' x Dos gh "\ s s \ s é er % x Ye é oS ¥ G5-5734 [uM] SP GS-5734 [uM] s GS-5734 [uM] ¥ ICs = 0.74UM ICs = 0. GS5734 Also Inhibits MERS-CoV replication in primary lung fib vascular endothelial cells at similar levels Sheahan et. al 2017 Science Translational Medic

This is our OCR of the page, with running headers and footers removed. The Committee's PDF is authoritative; quote from it. Machine-readable, including the uncleaned text: /api/page/letter_dni/43

Records on this page

RecordDateTypePages
letter_dni:exh:00034 attachment 43